Dr C Gelbmann, Department of Internal Medicine I, University of Regensburg, 93042 Regensburg, Germany. BACKGROUND/AIMS Intestinal fibrosis and stricture formation is an unresolved problem in Crohn’s ...

The Company will focus resources on advancing its lead asset, PYX-201- PYX-201 is a novel first-in-concept antibody-drug conjugate (ADC) where ...

payload that uniquely targets Extradomain-B Fibronectin (EDB+FN), a non-cellular structural component within the tumor extracellular matrix. In November 2024, Pyxis Oncology reported positive ...

"I was very young. She (Tina) was born, I was 19. Kitna choti thi main, I swear, maine toh college bhi nahi dekha hai," ...

Despite significant advances in oncology research, challenges remain as the American Cancer Society recently highlighted a sharp rise in early-onset colorectal cancer cases globally, signaling a ...

Bifikafusp alfa + onfekafusp alfa is under clinical development by Philogen and currently in Phase III for Metastatic Melanoma.

Sunita Ahuja wife of Govinda shares her heartbreaking loss of a premature child Learn about preterm labour causes symptoms and early interventions for better outcomes ...

Endothelial cells are also likely to participate in activation, both by production of cellular fibronectin and via conversion of transforming growth factor (TGF)-beta from the latent to active ...

ALA = Amoebic liver abscess; Eh = Entamoeba histolytica; EhCP = E. histolytica cysteine proteinase; Ehserp = E. histolytica serine proteinase; EhSTIRP = Serine threonine isoleucine-rich protein ...